All Pharma News
Zenas BioPharma Appoints Patricia Allen to its Board of Directors

Zenas BioPharma Appoints Patricia Allen to its Board of Directors
GLOBENEWSWIRE
06 Mar 2024
Share Share
Zenas BioPharma Strengthens Executive Leadership

Zenas BioPharma Strengthens Executive Leadership
GLOBENEWSWIRE
04 Dec 2023
Share Share
Zenas BioPharma Announces Strategic License and Collaboration Agreement with BMS

Zenas BioPharma Announces Strategic License and Collaboration Agreement with BMS
PRESS RELEASE
06 Sep 2023
Share Share
Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab
GLOBENEWSWIRE
01 Aug 2023
Share Share
Zenas Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab

Zenas Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab
GLOBENEWSWIRE
11 Jan 2023
Share Share
Zenas zips up $118M series B to launch phase 3 trial

Zenas zips up $118M series B to launch phase 3 trial
Gabrielle Masson FIERCEBIOTECH
08 Nov 2022
Share Share
Zenas BioPharma Secures $118 M to Advance Broad Pipeline of Autoimmune Disease

Zenas BioPharma Secures $118 M to Advance Broad Pipeline of Autoimmune Disease
GLOBENEWSWIRE
07 Nov 2022
Share Share
Zenas BioPharma Obtains IND Approval in China for PI/II Study of ZB001

Zenas BioPharma Obtains IND Approval in China for PI/II Study of ZB001
GLOBENEWSWIRE
01 Aug 2022
Share Share
Zenas BioPharma Obtains IND Approval in China for PI/II Study of ZB001

Zenas BioPharma Obtains IND Approval in China for PI/II Study of ZB001
GLOBENEWSWIRE
31 Jul 2022
Share Share
Zenas BioPharma Submits IND Application in China for ZB001 for TED

Zenas BioPharma Submits IND Application in China for ZB001 for TED
GLOBENEWSWIRE
15 May 2022
Share Share